BCAL Diagnostics Appoints CEO

Breast cancer screening and diagnostic company BCAL Diagnostics (ASX:BDX) named Shane Ryan as chief executive officer, effective April 2, to drive the company's commercialization strategy and launch i

MT NewswiresMar 5 18:28 ET

BCAL Diagnostics Joins Forces to Conduct Breast Cancer Blood Test Study in India

BCAL Diagnostics (ASX:BDX) joined forces with the Krishna Institute of Medical Sciences and the Basavatarakam Indo-American Hospital to conduct a pilot study for the use of the diagnostic firm's blood

MT NewswiresNov 29, 2023 01:57 ET

BCAL Diagnostics Secures AU$3 Million R&D Tax Rebate for Fiscal Year 2023; Shares Fall 5%

BCAL Diagnostics (ASX:BDX) secured a AU$3 million rebate for the fiscal year ended June 30 from the Australian government's research and development scheme, the diagnostic firm said on Tuesday. The sc

MT NewswiresNov 13, 2023 22:02 ET

BCAL Diagnostics Files for Additional Australian Patent Application

BCAL Diagnostics (ASX:BDX) filed for further provisional patent application in Australia. The application covered additional lipid biomarkers detected in the screening company's breast cancer diagnost

MT NewswiresNov 6, 2023 01:48 ET

Blood Screening Market Size to Grow by USD 1.17 Billion From 2022-2027| Apollo Hospitals Enterprise Ltd., Aster Clinical Lab LLP, BCAL Diagnostics Ltd., and More Among the Major Companies in the Market - Technavio

The Blood Screening Market size is expected to grow by USD 1.17 billion, accelerating at a CAGR of 7.42% during the forecast period, according to...

PR NewswireNov 2, 2023 19:45 ET

BCAL Diagnostics Appoints COO

BCAL Diagnostics (ASX:BDX) appointed Shane Ryan as chief operating officer, effective Sept. 21. Ryan was recently the global senior vice president strategy and innovation-patient access for GenesisCar

MT NewswiresSep 4, 2023 21:34 ET